Down-titration from high-dose combination therapy in asthma: Removal of long-acting β2-agonist
Open Access
- 31 August 2010
- journal article
- research article
- Published by Elsevier BV in Respiratory Medicine
- Vol. 104 (8), 1110-1120
- https://doi.org/10.1016/j.rmed.2010.04.003
Abstract
No abstract availableKeywords
This publication has 40 references indexed in Scilit:
- Expert Panel Report 3 (EPR-3): Guidelines for the Diagnosis and Management of Asthma–Summary Report 2007Journal of Allergy and Clinical Immunology, 2007
- Asthma control can be maintained when fluticasone propionate/salmeterol in a single inhaler is stepped downJournal of Allergy and Clinical Immunology, 2006
- Inflammatory subtypes in asthma: Assessment and identification using induced sputumRespirology, 2006
- Doubling the dose of budesonide versus maintenance treatment in asthma exacerbationsThorax, 2004
- Stepping down inhaled corticosteroids in asthma: randomised controlled trialBMJ, 2003
- Optimal asthma control, starting with high doses of inhaled budesonideEuropean Respiratory Journal, 2000
- The nasal air sampler: a device for sampling inhaled aeroallergensAnnals of Allergy, Asthma & Immunology, 2000
- Development and validation of a questionnaire to measure asthma controlEuropean Respiratory Journal, 1999
- Induced sputum eosinophil cationic protein (ECP) measurement in asthma and chronic obstructive airway disease (COAD)Clinical and Experimental Allergy, 1998
- A scale for the measurement of quality of life in adults with asthmaJournal of Clinical Epidemiology, 1992